U.S. FDA Approves ‘Brexpiprazole’ as Adjunctive Treatment for Adults with Major Depressive Disorder and as a Treatment for Adults with Schizophrenia

http://www.businesswire.com/news/home/20150710005794/en/U.S.-FDA-Approves-Otsuka-Lundbeck%E2%80%99s-REXULTI%C2%AE-Brexpiprazole#.VaCNLHO6bqA

image

Advertisements